KPT-330

A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy for Newly Diagnosed DIPG and High Grade Glioma
Status:

Open

Contact:

Jennifer Welch, MD
jwelch@lifespan.org